Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is positioned well in the growing behavioral health marketplace with its diverse range of services that cater to different levels of care and a well-diversified payor mix. The company has demonstrated strong same-facility admissions, while also facing some temporary challenges, such as soft CTC growth and a decline in specialty revenue. However, management has reorganized and is taking measures to address these issues, including hiring a former executive with expertise in denials and implementing cost efficiency programs. This, combined with the potential upside from Florida DPP benefits and continued growth in the ramping cohorts, has led to an upward revision of the 2026 EBITDA estimate. Management's attention to operational discipline and capital allocation, as well as the strong underlying demand for behavioral health services, support a positive outlook for Acadia Healthcare Co's stock.

Bears say

Acadia Healthcare Co is facing several fundamental risks, including market concentration and reimbursement risk due to its reliance on a small number of states for revenue and government reimbursement. There is also potential for exposure to government investigations and continued headline risk surrounding improper admission practices. Additionally, the company faces execution risk in its de novo development and ability to staff new capacity in the current labor environment. These risks, combined with recent negative developments such as a $2M increase in bad debt and denials in the most recent quarter, lead to a negative outlook and a price target of $30, representing a 7.8x EV/EBITDA multiple based on our 2027 Adj. EBITDA estimate and reflecting uncertainty for when volumes will recover.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of May 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.